Your browser doesn't support javascript.
loading
Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks.
Birring, Surinder S; Dicpinigaitis, Peter V; Smith, Jaclyn A; Morice, Alyn H; McGarvey, Lorcan P; Pavord, Ian D; Nguyen, Allison Martin; Schelfhout, Jonathan; Li, Qing; Iskold, Beata; Green, Stuart A; Philip, George; Muccino, David R; La Rosa, Carmen.
Afiliación
  • Birring SS; Centre for Human & Applied Physiological Sciences, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
  • Dicpinigaitis PV; Albert Einstein College of Medicine & Montefiore Medical Center, Bronx, New York.
  • Smith JA; Division of Immunology, Immunity to Infection & Respiratory Medicine, University of Manchester and Manchester University National Health Service Trust, Manchester, United Kingdom.
  • Morice AH; Hull York Medical School, Cottingham, United Kingdom.
  • McGarvey LP; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland.
  • Pavord ID; Oxford National Institute for Health Research Respiratory Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; and.
  • Nguyen AM; Merck & Co., Inc., Rahway, New Jersey.
  • Schelfhout J; Merck & Co., Inc., Rahway, New Jersey.
  • Li Q; Merck & Co., Inc., Rahway, New Jersey.
  • Iskold B; Merck & Co., Inc., Rahway, New Jersey.
  • Green SA; Merck & Co., Inc., Rahway, New Jersey.
  • Philip G; Merck & Co., Inc., Rahway, New Jersey.
  • Muccino DR; Merck & Co., Inc., Rahway, New Jersey.
  • La Rosa C; Merck & Co., Inc., Rahway, New Jersey.
Am J Respir Crit Care Med ; 207(11): 1539-1542, 2023 06 01.
Article en En | MEDLINE | ID: mdl-36996347

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antitusígenos / Tos Límite: Humans Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antitusígenos / Tos Límite: Humans Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido